Influence of prophylactic, endovascularly based normothermia on inflammation in patients with severe cerebrovascular disease: a prospective, randomized trial.
Broessner
Gregor
G
Department of Neurology, Neurologic Intensive Care Unit, Innsbruck Medical University, Austria. gregor.broessner@i-med.ac.at
Lackner
Peter
P
Fischer
Marlene
M
Beer
Ronny
R
Helbok
Raimund
R
Pfausler
Bettina
B
Schneider
Dietmar
D
Schmutzhard
Erich
E
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015415:Biomarkers; D001831:Body Temperature; D002097:C-Reactive Protein / Q000378:metabolism; D002561:Cerebrovascular Disorders / Q000473:pathology* / Q000628:therapy*; D003422:Critical Care; D005260:Female; D005334:Fever / Q000150:complications / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000473:pathology* / Q000517:prevention & control*; D016753:Interleukin-10 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012959:Socioeconomic Factors; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D015415:Biomarkers; D015850:Interleukin-6; D016753:Interleukin-10; D002097:C-Reactive Protein